Nutex Health Announces 1-for-15 Reverse Stock Split Effective From April 10, 2024; Number Of Common Shares Outstanding Will Be Reduced From Approximately 745M To 50M Shares

Author: Benzinga Newsdesk | April 05, 2024 05:33am

As a result of the reverse stock split, the number of common shares outstanding will be reduced from approximately 745 million shares to approximately 50 million shares, and the number of authorized shares of common stock will remain at 950 million shares.  In addition, the number of shares reserved for issuance under the Company's equity compensation plan immediately prior to the reverse stock split will be reduced proportionately.  Adjustments will also be made to the Company's outstanding warrants and stock options. The number of shares into which these securities are convertible or exercisable will be adjusted in line with the reverse split, as will the exercise prices of these securities.

Posted In: NUTX